First Trust NYSE Arca Biotechnology Index Fund Rating $171.75 -0.32 (-0.19%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy 2.68Holdings in FBT have an aggregate rating of Moderate Buy based on 441 analyst ratings issued in the past year covering 25 companies (86.6% of the portfolio).FBT Aggregate Price Target$171.75High Prediction$171.75Average Prediction$171.75Low Prediction$171.75Holdings in FBT have an aggregate price target of $171.75 and a range of $171.75 to $171.75 covering 25 companies (86.6% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FBT Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.60%ALNYAlnylam Pharmaceuticals$452.33-0.4%4.1677 of 5 stars2.85$405.33 -10.4%264.01%HALOHalozyme Therapeutics$72.81-0.5%4.7047 of 5 stars2.18$67.11 -7.8%11News CoveragePositive News3.99%ONCBeOne Medicines$297.96-0.7%1.4438 of 5 stars3.00$330.89 11.1%7Positive News3.95%INCYIncyte$83.70-1.3%4.6676 of 5 stars2.33$81.60 -2.5%18Positive News3.91%ACADACADIA Pharmaceuticals$26.23-1.3%4.0364 of 5 stars2.61$28.88 10.1%18Positive News3.76%ARGXargenex$704.07-0.5%3.0892 of 5 stars3.09$766.50 8.9%22Trending NewsAnalyst ForecastAnalyst RevisionGap Up3.67%GMABGenmab A/S$25.11+1.3%3.5764 of 5 stars2.64$37.60 49.7%11News CoveragePositive News3.65%VCYTVeracyte$29.95+4.7%2.3931 of 5 stars2.70$40.90 36.6%103.55%SRPTSarepta Therapeutics$18.34+1.5%4.553 of 5 stars2.07$43.50 137.2%29Analyst Forecast3.44%MTDMettler-Toledo International$1,284.28-0.1%3.978 of 5 stars2.50$1,311.11 2.1%10Positive News3.37%UTHRUnited Therapeutics$307.24+0.6%4.9273 of 5 stars2.69$382.00 24.3%13News CoveragePositive NewsAnalyst Revision3.34%GILDGilead Sciences$112.56-1.2%4.9733 of 5 stars2.88$115.39 2.5%26Positive News3.31%REGNRegeneron Pharmaceuticals$579.61-1.3%4.8516 of 5 stars2.81$817.67 41.1%27Trending NewsAnalyst Forecast3.31%BIIBBiogen$132.65-2.7%4.839 of 5 stars2.34$185.74 40.0%32Positive News3.29%NTRANatera$167.88+3.0%3.1236 of 5 stars3.06$193.19 15.1%18Positive News3.27%ILMNIllumina$99.17-0.4%4.6342 of 5 stars2.21$123.17 24.2%19Positive News3.24%KRYSKrystal Biotech$150.76+2.1%4.7131 of 5 stars3.00$210.38 39.5%93.23%NBIXNeurocrine Biosciences$138.94+0.6%4.891 of 5 stars2.86$159.50 14.8%21Positive News3.21%BMRNBioMarin Pharmaceutical$57.68-1.7%4.9963 of 5 stars2.72$93.17 61.5%25Positive News3.17%AMGNAmgen$285.61-0.8%4.7443 of 5 stars2.33$304.43 6.6%21Positive NewsAnalyst Forecast3.13%ALKSAlkermes$28.93-1.1%4.675 of 5 stars2.83$41.08 42.0%123.13%BNTXBioNTech$101.93-1.0%2.7288 of 5 stars2.76$135.80 33.2%17Positive News3.12%CORTCorcept Therapeutics$69.58-0.2%4.7619 of 5 stars3.00$134.50 93.3%5Positive News3.06%RGENRepligen$122.17+2.8%4.8584 of 5 stars2.73$169.45 38.7%11Positive News2.92%EXASExact Sciences$46.95+0.5%4.9332 of 5 stars2.91$67.05 42.8%23Positive News This page (NYSEARCA:FBT) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access